Cargando…
Dynamics of urine proteomics biomarker and disease progression in patients with IgA nephropathy
BACKGROUND: Immunoglobulin A nephropathy (IgAN) frequently leads to kidney failure. The urinary proteomics-based classifier IgAN237 may predict disease progression at the time of kidney biopsy. We studied whether IgAN237 also predicts progression later in the course of IgAN. METHODS: Urine from pati...
Autores principales: | Peters, Björn, Beige, Joachim, Siwy, Justyna, Rudnicki, Michael, Wendt, Ralph, Ortiz, Alberto, Sanz, Ana Belen, Mischak, Harald, Reich, Heather N, Nasic, Salmir, Mahmood, Dana, Persson, Anders, Fernström, Anders, Weiner, Maria, Stegmayr, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689155/ https://www.ncbi.nlm.nih.gov/pubmed/37349951 http://dx.doi.org/10.1093/ndt/gfad125 |
Ejemplares similares
-
Urine proteomics for prediction of disease progression in patients with IgA nephropathy
por: Rudnicki, Michael, et al.
Publicado: (2020) -
Proteomic characterization of obesity-related nephropathy
por: Wendt, Ralph, et al.
Publicado: (2020) -
Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review
por: Catanese, Lorenzo, et al.
Publicado: (2023) -
The association of erythropoietin-stimulating agents and increased risk for AV-fistula dysfunction in hemodialysis patients. A retrospective analysis
por: Wärme, Anna, et al.
Publicado: (2021) -
Histological diagnosis from kidney transplant biopsy can contribute to prediction of graft survival
por: Nasic, Salmir, et al.
Publicado: (2022)